UV

Udit Verma

Active Director Director DIN 08996698
DIN 08996698 First appointment Dec 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Udit Verma

Data last updated:

Udit Verma is a Director at Pharmtox Lifesciences Private Limited (since 2020). The company operates in Chemicals. Pharmtox Lifesciences Private Limited reported revenue of ₹1.05 Cr (FY 2025).

DIN 08996698
Primary Designation Director
Industry Chemicals
First Appointment 17 Dec 2020
Oldest Company Age 5 yrs
Largest company Pharmtox Lifesciences Private Limited · ₹1.05 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Dec 20202020₹1.05 Cr (FY 2025)Active

Board colleagues of Udit Verma

NameDINCompanyDesignation
Abhishek Verma08996449Pharmtox Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pharmtox Lifesciences Private Limited
Premium access

Shareholding and investment profile for Udit Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Udit Verma

Udit Verma currently holds 1 directorship: Pharmtox Lifesciences Private Limited (Director, since 17 Dec 2020, revenue ₹1.05 Cr (FY 2025)).

Udit Verma was first appointed on 17 Dec 2020 as Director at Pharmtox Lifesciences Private Limited.

The current boards of Udit Verma's companies include Abhishek Verma (Pharmtox Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available